Promising therapeutic targets for treatment of rheumatoid arthritis

J Huang, X Fu, X Chen, Z Li, Y Huang… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that
mainly damages the hands and feet, which affects 0.5% to 1.0% of the population …

Bioactive lipids, inflammation and chronic diseases

A Leuti, D Fazio, M Fava, A Piccoli, S Oddi… - Advanced Drug Delivery …, 2020 - Elsevier
Endogenous bioactive lipids are part of a complex network that modulates a plethora of
cellular and molecular processes involved in health and disease, of which inflammation …

Bioactive lipids and chronic inflammation: managing the fire within

V Chiurchiù, A Leuti, M Maccarrone - Frontiers in immunology, 2018 - frontiersin.org
Inflammation is an immune response that works as a contained fire that is pre-emptively
sparked as a defensive process during infections or upon any kind of tissue insult, and that …

Prostaglandin‐cytokine crosstalk in chronic inflammation

C Yao, S Narumiya - British journal of pharmacology, 2019 - Wiley Online Library
Chronic inflammation underlies various debilitating disorders including autoimmune,
neurodegenerative, vascular and metabolic diseases as well as cancer, where aberrant …

The Concise Guide to PHARMACOLOGY 2013/14: G protein‐coupled receptors

SPH Alexander, HE Benson… - British journal of …, 2013 - Wiley Online Library
Abstract The Concise Guide to PHARMACOLOGY 2013/14 provides concise overviews of
the key properties of over 2000 human drug targets with their pharmacology, plus links to an …

Prostaglandin E2 in the tumor microenvironment, a convoluted affair mediated by EP receptors 2 and 4

A Santiso, A Heinemann, J Kargl, M Gottesman - Pharmacological Reviews, 2024 - Elsevier
The involvement of the prostaglandin E2 (PGE2) system in cancer progression has long
been recognized. PGE2 functions as an autocrine and paracrine signaling molecule with …

The role of IL-17 and Th17 lymphocytes in autoimmune diseases

J Tabarkiewicz, K Pogoda, A Karczmarczyk… - Archivum immunologiae …, 2015 - Springer
The end of twentieth century has introduced some changes into T helper (Th) cells division.
The identification of the new subpopulation of T helper cells producing IL-17 modified model …

International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress

DF Woodward, RL Jones, S Narumiya - Pharmacological reviews, 2011 - Elsevier
It is now more than 15 years since the molecular structures of the major prostanoid receptors
were elucidated. Since then, substantial progress has been achieved with respect to …

Prostaglandins and chronic inflammation

T Aoki, S Narumiya - Trends in pharmacological sciences, 2012 - cell.com
Chronic inflammation is the basis of various chronic illnesses including cancer and vascular
diseases. However, much has yet to be learned how inflammation becomes chronic …

The prostanoid EP4 receptor and its signaling pathway

U Yokoyama, K Iwatsubo, M Umemura, T Fujita… - Pharmacological …, 2013 - Elsevier
The EP4 prostanoid receptor is one of four receptor subtypes for prostaglandin E 2. It
belongs to the family of G protein–coupled receptors. It was originally identified, similar to …